Das Galavit-Forum. > Die Akte Dr. Kurt Donsbach

Ralph W. Moss über Donsbach


Zitat aus



Last week I began telling you about
Galavit, a Russian drug that has been
widely touted as a valuable treatment for
cancer. Much of the enthusiasm for
Galavit in the English-speaking world
has been generated by Dr. Kurt
Donsbach, a chiropractor who directs
the Santa Monica clinic of Rosarita
Beach, Mexico.

In March 2001, Dr. Donsbach reported
in his 'Let's Talk' newsletter that he had
attended a conference in Rumania, the
purpose of which was to launch Galavit
outside Russia.

He stated that this meeting was attended
by "a limited group of oncologists from
around the world". However, the alleged
facts concerning the efficacy of the
drug, and the substance of the
discussions that purportedly took place
at the Romanian conference, have never
been made available for independent

On what basis did Dr. Kurt Donsbach
make his startling allegations about its
effectiveness? "Because I talked to
traditional German oncologists," he says,
"who have used Galavit for two years
on some of their worst cases - ones
which their surgery, radiation and
chemotherapy had failed and they knew
of nothing else."

As a sole example, he reports that Dr.
Eike Rauchfuss, whom he describes as
an oncological surgeon of 25 years'
standing, "was almost embarrassed into
using Galavit", when a patient whom he
had already informed there was nothing
more that could be done, went to
Russia, purchased Galavit, brought it
back to Germany and asked him to
administer it.
He refused because it was not licensed
or approved in Germany. The patient
asked him if he were so inhumane that
he would not help a dying person.
"Reluctantly," says Donsbach, "he gave
her the full 30 doses of the Galavit and
saw a dramatic improvement in her
condition", leading to what eventually
was considered a full remission.
That piqued his curiosity and he has
treated over 400 patients under the
German "compassionate care" provision
of the medical law since that time. His
words to me were that "over 80 percent
of these patients were successfully
treated with Galavit."

I do not know Dr. Eike Rauchfuss.
There is, however, an E. Rauchfuss
who wrote 15 articles listed in PubMed.
Three of these articles relate to cancer,
the most recent one having been
published in 1989. This E. Rauchfuss
appears to have been a gastrointestinal
surgeon in the former East Germany,
which jibes with German newspaper

At the Galavit.ru website his address is
given as the European Oncology
Institute for Immunodiagnostics,
Immunotherapy and Protonic Irradiation
in Bad Karlshafen. Bad Karlshafen is a
spa town located just north of Kassel, in
the state of Hesse.

But other than the Galavit site itself
there are no references on the Internet
to this "Institute" in Bad Karlshafen or
elsewhere in Germany. In some German
newspaper articles from 2001, his
practice was described as being located
in Bad Heilbrunn, a small town in
Germany, which I once visited as the
home base of the "immunotherapy"
clinic of Dr. Nikolaus W. Klehr.
According to at least one website, both
therapies were given together at the
same clinic.

The price of Galavit in Germany started
at DM 16,800 and went up from there.
At the time this was equal to US $9,500.
According to a newspaper account, Dr.
Rauchfuss treated at least 200 patients in
Bad Heilbrunn in this manner, for a
gross income of around two million US
dollars. At the same time, the retail cost
of Galavit in Russia was a fraction of

And, if Galavit is indeed nothing more
than luminol, then the raw material cost
of each injection was around 50 cents,
or $10 for a course of 20 such

Documentation of Effects?

At the Galavit website they give a
bibliography consisting of eight citations,
but none more recent than the year
2000. One article has to do with the
treatment of ulcers. Another concerns
immunity-directed therapy.
The third is about the use of Galavit "to
reduce expressiveness of early
radiotherapeutical impairments."
Another is on a "new native
immunomodulating and
anti-inflammatory drug."

Aside from the Rauchfuss claims, there
is only one publication by A. F. Tsyb
(1999) specifically on cancer. This
article was published in the International
Journal on Immunorehabilitation.
The International Journal on
Immunorehabilitation is a Russian
journal described elsewhere as the
"Official Organ of International
Scientific Society for
I could find only passing mention of
such a Society on the Internet. No such
article or even journal is listed in
PubMed. Dr. A. F. Tsyb does have
about 150 articles in PubMed, but in
recent years these have mainly dealt
with the after-effects of the Chernobyl
nuclear catastrophe.
He is at the Medical Radiological
Research Centre of the Russian
Academy of Medical Sciences, Obninsk.

On August 26, 2003 I spoke to Dr. Kurt
Donsbach. He told me an involved story
of the financial wheeling-dealing around
the treatment and how the price was
driven up for Western consumption.

On the clinical side, he said that while he
had seen some improvement in blood
work in cancer patients to whom he
gave Galavit, it did not seem to have any
specific effect on the tumor's growth.
And so he stopped using it almost a year

Unfortunately, as I pointed out, his
various websites still featured glowing
accounts of this drug, based entirely on
unsubstantiated claims and anecdotes.

Dr. Donsbach assured me that the
websites were being revised, "as we
speak", to remove all mention of
Galavit. However, six weeks later
(October 11, 2003) the glowing article
had still not been removed.

Lessons of Galavit

Unfortunately, the Galavit story is a
familiar one. A new cancer treatment is
launched with a captivating story and a
certain degree of plausibility. In the case
of Galavit, Russia has an excellent
scientific educational system but much
of its best work was walled off from the
rest of the world during the Soviet

Why shouldn't an exciting new drug
have been discovered as part of the
Soviet Union's space program? This
could plausibly explain the secrecy
surrounding Galavit and why nobody in
the West had ever heard of this
development before.

The new discovery is then uncovered by
an intrepid investigator (such as a patient
of Russian origin, like Ivan Desny) and
enthusiastically promoted by a few
doctors in the West. They, in turn,
manage to convince a few journalists to
run stories on its alleged benefits.
Yet the entire promotion is based on
exaggerated, or even fabricated, claims.
Nonetheless, the treatment begins to
pick up steam and the story is publicized
by the sensationalist or (as they say in
Germany) the "boulevard press" and by
some less than scrupulous television
stations and websites.

Predictably, it is denounced by the
cancer authorities, often in sweepingly
negative terms which, paradoxically,
may only serve to fuel the rumors of the
treatment's revolutionary nature.

Hundreds of patients are then primed to
pay thousands of dollars in a desperate
search for a cure for themselves or a
loved one. Eventually the treatment is
shown not to work.

The supposed documentation of
beneficial effects turns out to be scanty
or even fraudulent. The scientists
mentioned as inventors of the treatment
disavow any connection to it and the
resumes of the Western doctors
involved are examined more closely and
are found to be wanting.

Generally speaking, the proponents fold
their tents and move on to other things,
perhaps surfacing shortly afterwards
with a new and improved "cancer cure."

The root cause of all this is human
greed. The desperation of cancer
patients presents an irresistible target for
charlatans of all kinds.

The sad truth is that advanced cancer is
difficult to cure, and there are pitifully
few really good treatments available. I
do not offer the following observation as
an excuse for the purveyors of
fraudulent treatments, but we must bear
in mind that Big Pharma and the Big
Media (the two being closely connected)
also play their own variant on this
cancer "Schwindel."

They use their enormous influence over
public opinion to ballyhoo the latest
breakthrough treatment, be it radiation,
chemo or gene therapy, until that too
falls by the wayside.

As I have shown many times, the
number of treatments that have actually
been proven, in randomized controlled
trials (RCTs), to extend the life of
patients, is surprisingly small.
I don't think the answer is to become a
hardened cynic with regard to new or
alternative cancer treatments. In many
ways that is even worse than being too
trusting, for it prejudges and effectively
rejects potentially beneficial new
treatments when they do come along.
What is needed is an open-minded
attitude towards new treatments
combined with a searching attempt to
get at the bedrock truth concerning any
proposed treatment for this intractable
disease. In other words, the approach
that I characterize as "friendly
--Ralph W. Moss, PhD October, 2003
Posted October, 2005

Galavit is a gigantic fraud!


Marke: 2000


[0] Message Index

Go to full version